Goldman Sachs Group »

Immunic shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Immunic (IMUX) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Immunic

Tip: Access up to 7 years of quarterly data

All positions including Immunic held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunic by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $166k 150k 1.11
2024-03-31 $18k 14k 1.32
2023-03-31 $50k 34k 1.49
2022-06-30 $93k 27k 3.46
2022-03-31 $2.8M 246k 11.30
2021-12-31 $1.7M 176k 9.57
2021-09-30 $1.5M 168k 8.85
2020-12-31 $348k 23k 15.30
2020-09-30 $402k 22k 18.55